| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.14% |
| NAV | ₹8.43 (28 Sep 2020) |
|---|---|
| Fund Started | 18 Jan 2018 |
| Fund Size | ₹62 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Bayer CropScience Ltd. | Healthcare | Equity | 6.5% |
| CreditAccess Grameen Ltd. | Financial | Equity | 6.0% |
| Valiant organics Ltd | Healthcare | Equity | 6.0% |
| Mastek Ltd. | Technology | Equity | 5.9% |
| Balrampur Chini Mills Ltd. | FMCG | Equity | 5.8% |
| Procter & Gamble Health Ltd. | Healthcare | Equity | 5.6% |
| Birla Corporation Ltd. | Construction | Equity | 5.2% |
| Jyothy Labs Ltd. | FMCG | Equity | 3.8% |
| KPIT Technologies Ltd. | Technology | Equity | 3.5% |
| KRBL Ltd. | FMCG | Equity | 3.2% |
Nippon India Capital Builder Fund IV Series D Regular Dividend is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 18 Jan 2018. Jahnvee Shah, Manish Gunwani, Meenakshi Dawar, Dhrumil Shah is the Current Fund Manager of Nippon India Capital Builder Fund IV Series D Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹62 Cr and the Latest NAV as of 28 Sep 2020 is ₹8.43.
The Nippon India Capital Builder Fund IV Series D Regular Dividend is rated Moderately High risk.
The scheme seeks to provide capital appreciation to the investors, which will be in line with their long term savings